comparemela.com
Home
Live Updates
Researchgate Gerdr Burmester - Breaking News
Pages:
Latest Breaking News On - Researchgate gerdr burmester - Page 1 : comparemela.com
Upadacitinib Demonstrates Higher Rates of Adverse Events Compared with Adalimumab in PsA
Both overall TEAEs and serious TEAEs were numerically higher in those receiving upadacitinib compared with adalimumab.
Berlin
Germany
Researchgate-gerdr-burmester
Gerdr-burmester
University-hospital
Department-of-rheumatology
Clinical-immunology
More Than Half of RA Patients Achieve Remission After Upadacitinib 15 mg
An extension study showed upadacitinib 15 mg and 30 mg for rheumatoid arthritis continues to be favorable, with many patients achieving remission.
Researchgate-gerdr-burmester
Gerdr-burmester
American-college-of-rheumatology
Clinical-disease-activity-index
Disease-activity-scorec-reactive
American-college
Nra
Upadacitinib
Tofacitinib Shows Similar Safety Profile in PsA, RA Post-Marketing Data
Researchers report on the global real-world safety profile of tofacitinib in psoriatic arthritis.
Germany
Berlin
Researchgate-gerdr-burmester
Gerdr-burmester
Pfizer
University-hospital
vimarsana © 2020. All Rights Reserved.